US Patent 7494773 Nucleotide sequences specific to
Patent 7494773 was granted and assigned to Lawrence Livermore National Security (company) on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Gary L. Andersen0
Linda L. Ott0
Lyndsay Radnedge0
Paula M. McCready0
Thomas A. Kuczmarski0
Thomas R. Slezak0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+354 characters)
Article
Patent abstract
Nucleotide sequences specific to Brucella that serves as a marker or signature for identification of this bacterium were identified. In addition, forward and reverse primers and hybridization probes derived from these nucleotide sequences that are used in nucleotide detection methods to detect the presence of the bacterium are disclosed.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07494773 Nucleotide sequences specific to US Patent 7494773 Nucleotide sequences specific to
Infobox
Patent Number
074947730
Patent Number
74947730
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074947730
Date of Patent
February 24, 2009
0Patent Application Number
106306070
Date Filed
July 29, 2003
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07494773 Nucleotide sequences specific to
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07494773
Date of patent
February 24, 2009
Patent application number
10630607
Date Filed
July 29, 2003
Patent primary examiner
Find more entities like US Patent 7494773 Nucleotide sequences specific to
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
